中医药治疗血吸虫病肝纤维化的研究进展  

Research Progress of Traditional Chinese Medicine in the Treatment of Schistosomiasis with Liver Fibrosis

作　　者：于鹏 YU Peng(Department of Traditional Chinese Medicine,Poyang County Schistosomiasis Control Station,Jiangxi Province,Poyang 333100,China)

机构地区：[1]江西省鄱阳县血吸虫病防治站中医科,江西鄱阳333100

出　　处：《中国中医药现代远程教育》2024年第10期158-160,共3页Chinese Medicine Modern Distance Education of China

基　　金：江西省中医药管理局科技项目【No.2021B135】。

摘　　要：血吸虫病是严重威胁人类生命健康的一种寄生虫病,而肝纤维化是血吸虫病患者死亡的主要原因之一。吡喹酮是当前用于血吸虫感染病原学治疗的少有的商品化口服药物,以吡喹酮化疗为主的防治策略极大地降低了我国人群血吸虫感染率和患者感染度,亦有明显的抗纤维化作用。中医治疗能够延缓、逆转血吸虫病肝纤维化。文章总结了近些年中医药在血吸虫病肝纤维化治疗中的研究进展,希望能从中探求新的方法,为临床上合理采用中医药预防和治疗血吸虫病肝纤维化提供依据。Schistosomiasis is a serious threat to human life and health,but one of the main causes of death of schistosomiasis patients.Praziquantel is a rare commercial oral drug used in the etiological treatment of schistosomiasis infection.The control strategy based on praziquantel chemotherapy greatly reduces the infection rate of schistosomiasis in Chinese population and the infection degree of patients,and also has obvious anti-fibrosis effect.In the treatment of schistosomiasis liver fibrosis,traditional Chinese medicine can delay and reverse liver fibrosis.This article summarizes the research progress of traditional Chinese medicine in the treatment of liver fibrosis in schistosomiasis in recent years,hoping to explore new methods and provide a basis for the reasonable use of traditional Chinese medicine in the prevention and treatment of liver fibrosis in schistosomiasis.

关 键 词：积证 血吸虫病 肝纤维化 中医药疗法 综述 

分 类 号：R259[医药卫生—中西医结合]